Among these names were Peter Stein, director of the FDA's Office of New Drugs; Brian King, director of the FDA's Center for Tobacco Products; Jeanne Marrazzo, M.D., director of the National ...
By Cade Metz The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer. By Michael J. de la Merced The outlet has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback